Rituximab for the treatment of rheumatiod arthritis patients with failure to the first biologic drug: Impact on Republic fund for health insurance in Serbia
Considering high prices of biologic drugs, using a cost-effective option for treatment of patients with rheumatoid arthritis who did not respond well to first biologic drug would have highly beneficial impact on health insurance budget. The aim of this study was to explore impact on budget of Republ...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Medicinsko društvo za racionalnu terapiju Republike Srbije
2013-01-01
|
| Series: | Racionalna Terapija |
| Subjects: | |
| Online Access: | http://scindeks-clanci.ceon.rs/data/pdf/1821-0538/2013/1821-05381301001J.pdf |